Increased proteolysis of antithrombin III Vicenza during disseminated intravascular coagulation in acute leukemia.
Castaman
G
G
Department of Hematology and Hemophilia, San Bortolo Hospital, Vicenza, Italy.
Ruggeri
M
M
Rodeghiero
F
F
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000990:Antithrombin III / Q000378:metabolism*; D020152:Antithrombin III Deficiency; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D004211:Disseminated Intravascular Coagulation / Q000097:blood* / Q000209:etiology; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D013866:Thioguanine / Q000008:administration & dosage; D013917:Thrombin / Q000378:metabolism; D013924:Thrombophlebitis / Q000235:genetics
D005338:Fibrin Fibrinogen Degradation Products; C038873:antithrombin III Vicenza; D003561:Cytarabine; D000990:Antithrombin III; D005340:Fibrinogen; D013917:Thrombin; D013866:Thioguanine; D003630:Daunorubicin